iiinova — where your digital self keeps evolving

Guillermo Canudo Barreras @gcanudo-barreras.bsky.social · 11/02/2026

Big milestone for our team! 🧪 We have officially filed a European patent for our latest advances in copper-based chemotherapeutic agents. Honored to work alongside @conchitagimeno.bsky.social , Raquel P. Herrera and E. Romanos on this. Thanks for the support! 💸 #Metallodrugs #Cancer

Infographic illustrating a European patent application for "Copper-based chemotherapeutics." A central copper atom (Cu) is shown with connecting lines pointing to three panels representing the treatment targets: Breast Cancer, Cervical Cancer, and Pancreatic Cancer. Each panel depicts the respective organ alongside an icon of a fragmenting tumor, indicating the therapeutic effect.

141

Guillermo Canudo Barreras @gcanudo-barreras.bsky.social · 26/01/2026

So proud to see our cover of the Journal of Medicinal Chemistry! 🧪🎨 We introduce ViVo, a new framework for temporal modeling designed to maximize data quality and minimize animal usage. 📉🐁 @conchitagimeno.bsky.social Link: pubs.acs.org/doi/10.1021/... #Science #MedChem #DrugDevelopment #ViVo

Cover of Journal of Medicinal Chemistry. The artwork illustrates the ViVo temporal modeling framework, showing a blend of advanced statistical data visualizations and biological research elements to represent the reduction of animal usage in drug discovery.

022

Guillermo Canudo Barreras @gcanudo-barreras.bsky.social · 16/10/2025

🧬 We just launched 𝐕𝐢𝐕𝐨! An open-source platform for 𝘪𝘯 𝘷𝘪𝘷𝘰 efficacy assays.⁣ Built with automated tumor kinetic analysis to boost preclinical oncology while minimizing animal usage.⁣ 📚 Methodology: doi.org/10.1101/2025... 🐁 Try: gcanudo-barreras.github.io/ViVo-Platfor... ⁣ #OpenScience #Oncology

doi.org

ViVo: A temporal modeling framework that boosts statistical power and minimizes animal usage

Preclinical tumor studies are often limited by high variability and small sample sizes, reducing statistical power and masking treatment effects. We present an exponential framework that estimates tum...

111

Guillermo Canudo Barreras @gcanudo-barreras.bsky.social · 03/07/2025

Excited to share some of our latest work with @conchitagimeno.bsky.social on light-tracing organometallic drugs at the XL Bienal of @rseq-quimica.bsky.social in Bilbao!

A researcher giving an oral presentation at the XL Bienal of @rseq-quimica.bsky.social in Bilbao, standing next to a projected slide showing data on light-tracing organometallic drugs.

131

Guillermo Canudo Barreras @gcanudo-barreras.bsky.social · 06/06/2025

Talking a bit about our recent work on quantifying tumor growth through tumor kinetics modeling at the IV Symposium on Molecular Chemistry and Catalysis organized by #ISQCH. #DrugDevelopment #MedicinalChemistry #CancerResearch #Pharmacokinetics #ChemistryResearch

Researcher presenting work on tumor kinetics modeling for novel anticancer drug development at the IV ISQCH Symposium. Standing next to a projected slide.

010

Guillermo Canudo Barreras @gcanudo-barreras.bsky.social · 15/04/2025

In today’s episode of “Science, Please Stop”, salmon on benzos are throwing caution (and themselves) to the current. Truth is stranger than fiction. 𝘚𝘤𝘪𝘦𝘯𝘤𝘦𝘈𝘥𝘷𝘪𝘴𝘦𝘳: 𝘉𝘦𝘯𝘻𝘰𝘴 𝘭𝘦𝘢𝘥 𝘵𝘰 𝘳𝘪𝘴𝘬𝘺 𝘣𝘦𝘩𝘢𝘷𝘪𝘰𝘳—𝘪𝘯 𝘴𝘢𝘭𝘮𝘰𝘯 www.science.org/content/arti...

science.org

ScienceAdviser: Benzos lead to risky behavior—in salmon

Today in Science and science: Evidence against ‘digital dementia’, what we’re enjoying this week, and more

000

Guillermo Canudo Barreras @gcanudo-barreras.bsky.social · 12/04/2025

What often scares us most about AI are the very behaviors we exhibit ourselves. Take the "reward hacking" phenomenon, where models try to bypass system rules to optimize outcomes. It feels like cheating—but maybe it's just one of the earliest signs of intelligence, artificial or natural.

010